NCT03247920 - Reduction of Intravenous Antibiotics In Neonates | Biotech Hunter

Enrollment

510

Participants

Timeline

Start Date

November 4, 2017

Primary Completion Date

June 15, 2021

Study Completion Date

July 15, 2021

Conditions

Neonatal InfectionNeonatal SEPSIS

Interventions

DRUG

Amoxicillin Clavulanate

Dose 75 mg/kg/day, (3dd 25 mg/kg). Concentration amoxicillin/clavulanic acid: 4:1

DRUG

Antibiotics

Intravenous antibiotic therapy following local protocol

Trial Locations (18)

Meander Medical Center, Amersfoort

Rijnstate Hospital, Arnhem

Amphia Hospital, Breda

IJsselland Ziekenhuis, Capelle aan den IJssel

Reinier de Graaf Gasthuis, Delft

Catharina Hospital, Eindhoven

Medisch Spectrum Twente, Enschede

Groene Hart Ziekenhuis, Gouda

Sint Antonius Ziekenhuis, Nieuwegein

Erasmus MC-Sophia Children's Hospital, Rotterdam

Franciscus Gasthuis, Rotterdam

Ikazia Ziekenhuis, Rotterdam

Maasstad Hospital, Rotterdam

Franciscus Vlietland, Schiedam

Haaglanden Medical Center, The Hague

Juliana Kinderziekenhuis-Haga Hospital, The Hague

Maxima Medisch Centrum, Veldhoven

Isala, Zwolle